Why Environmentalists Should Be Concerned
By Bill McKibben,
WorldWatch
| 06. 30. 2002
July / August 2002
It's not as if environmentalists really need something new to worry about. The planet's temperature is set to rise four or five degrees-every glacial system is already in rapid retreat, and icebergs measured in units of U.S. states (the size of Rhode Island!) are calving off the Antarctic. Species disappear daily; acid rain; and you know the whole damn litany. We could be forgiven for wanting to take a pass on human genetic engineering.
And yet I think it may turn into the single greatest battle environmentalists have ever fought, the one for which the Grand Canyon and the African elephants and Amazon deforestation and Love Canal were preparing us. The real test.
Some of the reasons for thinking so are pragmatic. Changing the human germline is an almost preposterous override of the precautionary principle, the idea that if you don't know something's safe you shouldn't do it. We have rushed with blinding speed through the first phases of the biotechnological revolution-what was experimental a decade ago now grows in half the corn and soybean fields...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...